{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:57:14Z","timestamp":1789952234361,"version":"4.0.1"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":2227,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"\u2018Cinque per mille of IRPEF-Finanziamento della ricerca sanitaria\u2019 and from the Italian Ministry of Health \u2018Ricerca Corrente contributo per la ricerca intramuraria\u2019 to Istituto Giannina Gaslini"},{"name":"Renal Child Foundation and Fondazione La Nuova Speranza"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,13]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Minimal change nephrosis (MCN) is an important cause of morbidity in children. In spite of successful therapies having been developed in the last three decades, most aspects related to pathogenesis still remain poorly defined. Evolution in basic immunology and results deriving from animal models of the disease suggest a complex interaction of factors and cells starting from activation of innate immunity and continuing with antigen presentation. Oxidants, CD80 and CD40\/CD40L have probably a relevant role at the start. Studies in animal models and in human beings also suggest the possibility that the same molecules (i.e. CD80, CD40) are expressed by podocytes under inflammatory stimuli, representing a direct potential mechanism for proteinuria. B and T cells could play a relevant role this contest. Implication of B cells is suggested indirectly by studies utilizing anti-CD20 monoclonal antibodies as the main therapy. The role of regulatory T cells (Tregs) is supported mainly by results in animal models of nephrotic syndrome (i.e. adriamycin, puromycin, lipopolysaccharide), showing a protective effect of direct Treg infusion or stimulation by interleukin 2 (IL-2). Limited studies have also shown reduced amounts of circulating Tregs in patients with active MCN cells. The route from bench to bedside would be reduced if results from animal models were confirmed in human pathology. The expansion of Tregs with recombinant IL-2 and new anti-CD20 monoclonal antibodies is the beginning. Blocking antigen-presenting cells with cytotoxic T lymphocyte antigen (CTLA-4)\u2013Ig fusion molecules inhibiting CD80 and\/or with blockers of CD40\u2013CD40 ligand interaction represent potential new approaches. The hope is that evolution in therapies of MCN could fill a gap lasting 30 years.<\/jats:p>","DOI":"10.1111\/cei.12675","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T16:03:06Z","timestamp":1435939386000},"page":"166-174","source":"Crossref","is-referenced-by-count":66,"title":["Regulatory T cells and minimal change nephropathy: in the midst of a complex network"],"prefix":"10.1093","volume":"183","author":[{"given":"R","family":"Bertelli","sequence":"first","affiliation":[{"name":"Laboratory on Physiopathology of Uremia, Children\u2019s Hospital, Genoa, Italy"},{"name":"Division of Nephrology, Dialysis, Transplantation, Giannina Gaslini Children\u2019s Hospital, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bonanni","sequence":"additional","affiliation":[{"name":"Laboratory on Physiopathology of Uremia, Children\u2019s Hospital, Genoa, Italy"},{"name":"Division of Nephrology, Dialysis, Transplantation, Giannina Gaslini Children\u2019s Hospital, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Di Donato","sequence":"additional","affiliation":[{"name":"Laboratory on Physiopathology of Uremia, Children\u2019s Hospital, Genoa, Italy"},{"name":"Division of Nephrology, Dialysis, Transplantation, Giannina Gaslini Children\u2019s Hospital, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cioni","sequence":"additional","affiliation":[{"name":"Laboratory on Physiopathology of Uremia, Children\u2019s Hospital, Genoa, Italy"},{"name":"Division of Nephrology, Dialysis, Transplantation, Giannina Gaslini Children\u2019s Hospital, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ravani","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G M","family":"Ghiggeri","sequence":"additional","affiliation":[{"name":"Laboratory on Physiopathology of Uremia, Children\u2019s Hospital, Genoa, Italy"},{"name":"Division of Nephrology, Dialysis, Transplantation, Giannina Gaslini Children\u2019s Hospital, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"2021111804085786700_cei12675-bib-0001","first-page":"181","article-title":"Clinical practice guideline for glomerulonephritis","volume":"2","author":"Kidney Disease Improving Global Outcomes (KDIGO)","year":"2012","journal-title":"Kidney Int"},{"key":"2021111804085786700_cei12675-bib-0002","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0140-6736(85)91387-X","article-title":"Long-term outcome for children with minimal-change nephrotic syndrome","volume":"1","author":"Trompeter","year":"1985","journal-title":"Lancet"},{"key":"2021111804085786700_cei12675-bib-0003","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney Int"},{"key":"2021111804085786700_cei12675-bib-0004","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.clinthera.2004.09.012","article-title":"Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study","volume":"26","author":"Ghiggeri","year":"2004","journal-title":"Clin Ther"},{"key":"2021111804085786700_cei12675-bib-0005","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2215\/CJN.05691108","article-title":"Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children","volume":"4","author":"Kyrieleis","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0006","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"2021111804085786700_cei12675-bib-0007","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/ndt\/gfh615","article-title":"Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature","volume":"20","author":"Karras","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2021111804085786700_cei12675-bib-0008","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1517\/14728222.12.6.769","article-title":"Regulatory T cells as therapeutic target in Hodgkin\u2019s lymphoma","volume":"12","author":"Koenecke","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"2021111804085786700_cei12675-bib-0009","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.1991.232","article-title":"A glomerular permeability factor produced by human T cell hybridomas","volume":"40","author":"Koyama","year":"1991","journal-title":"Kidney Int"},{"key":"2021111804085786700_cei12675-bib-0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ki.1991.293","article-title":"T-lymphocyte subsets in nephrotic syndrome","volume":"40","author":"Fiser","year":"1991","journal-title":"Kidney Int"},{"key":"2021111804085786700_cei12675-bib-0011","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/ajkd.2002.32769","article-title":"T-lymphocyte populations and cytokines in childhood nephrotic syndrome","volume":"39","author":"Lama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2021111804085786700_cei12675-bib-0012","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0272-6386(12)80742-6","article-title":"Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans","volume":"21","author":"Suranyi","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"2021111804085786700_cei12675-bib-0013","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2362.1994.tb02022.x","article-title":"Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome","volume":"24","author":"Bustos","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"2021111804085786700_cei12675-bib-0014","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","article-title":"T regulatory cell function in idiopathic minimal lesion nephrotic syndrome","volume":"24","author":"Araya","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"2021111804085786700_cei12675-bib-0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2249.1995.tb03725.x","article-title":"Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome","volume":"100","author":"Neuhaus","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2021111804085786700_cei12675-bib-0016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004670050592","article-title":"Up-regulation of interleukin-4 and CD23\/FcepsilonRII in minimal change nephrotic syndrome","volume":"13","author":"Cho","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"2021111804085786700_cei12675-bib-0017","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1994.171","article-title":"IL-8 production by peripheral blood mononuclear cells in nephrotic patients","volume":"45","author":"Garin","year":"1994","journal-title":"Kidney Int"},{"key":"2021111804085786700_cei12675-bib-0018","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats","volume":"18","author":"Lai","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0019","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.2010.04160.x","article-title":"Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome","volume":"161","author":"Bertelli","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021111804085786700_cei12675-bib-0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2249.2011.04441.x","article-title":"Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome","volume":"166","author":"Bertelli","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"2021111804085786700_cei12675-bib-0021","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1016\/j.bbagen.2013.04.017","article-title":"Oxidized albumin. The long way of a protein of uncertain function","volume":"1830","author":"Bruschi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2021111804085786700_cei12675-bib-0022","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1681\/ASN.2006090965","article-title":"Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin","volume":"18","author":"Musante","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0023","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/pmic.200800254","article-title":"New iodo-acetamido cyanines for labeling cysteine thiol residues. A strategy for evaluating plasma proteins and their oxido-redox status","volume":"9","author":"Bruschi","year":"2009","journal-title":"Proteomics"},{"key":"2021111804085786700_cei12675-bib-0024","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ki.1991.176","article-title":"Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro","volume":"40","author":"Ghiggeri","year":"1991","journal-title":"Kidney Int"},{"key":"2021111804085786700_cei12675-bib-0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/cs0780283","article-title":"Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis","volume":"78","author":"Ginevri","year":"1990","journal-title":"Clin Sci (Lond)"},{"key":"2021111804085786700_cei12675-bib-0026","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0027","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int"},{"key":"2021111804085786700_cei12675-bib-0028","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2014080799","article-title":"Rituximab in children with steroid-dependent nephrotic syndrome: a multicenter, open-label, noninferiority, randomized controlled trial","author":"Ravani","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0029","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2005-04-1769","article-title":"Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor","volume":"107","author":"Perosa","year":"2006","journal-title":"Blood"},{"key":"2021111804085786700_cei12675-bib-0030","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-015-9457-4","article-title":"Beyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161","author":"Bai","year":"2015","journal-title":"Purinergic Signal"},{"key":"2021111804085786700_cei12675-bib-0031","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"2021111804085786700_cei12675-bib-0032","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/sji.12025","article-title":"Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: the role of interleukin-17 suppression?","volume":"77","author":"Park","year":"2013","journal-title":"Scand J Immunol"},{"key":"2021111804085786700_cei12675-bib-0033","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4049\/jimmunol.1302171","article-title":"B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system","volume":"192","author":"Pierson","year":"2013","journal-title":"J Immunol"},{"key":"2021111804085786700_cei12675-bib-0034","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss): state of the art","volume":"68","author":"Vaglio","year":"2913","journal-title":"Allergy"},{"key":"2021111804085786700_cei12675-bib-0035","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.30314","article-title":"The anti-CD20 antibody rituximab reduces the Th17 cell response","volume":"63","author":"van de Veerdonk","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021111804085786700_cei12675-bib-0036","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/s10165-009-0244-3","article-title":"Analysis of cytokine production patterns of peripheral blood mononuclear cells from a rheumatoid arthritis patient successfully treated with rituximab","volume":"20","author":"Yamamoto","year":"2010","journal-title":"Mod Rheumatol"},{"key":"2021111804085786700_cei12675-bib-0037","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"2021111804085786700_cei12675-bib-0038","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.immunol.19.1.375","article-title":"The immunological synapse","volume":"19","author":"Bromley","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"2021111804085786700_cei12675-bib-0039","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/356607a0","article-title":"CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones","volume":"356","author":"Harding","year":"1992","journal-title":"Nature"},{"key":"2021111804085786700_cei12675-bib-0040","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/70905","article-title":"T-cell stimulation: an abundance of B7s","volume":"5","author":"Abbas","year":"1999","journal-title":"Nat Med"},{"key":"2021111804085786700_cei12675-bib-0041","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-5699(98)01418-2","article-title":"Structure and evolution of the extended B7 family","volume":"20","author":"Henry","year":"1999","journal-title":"Immunol Today"},{"key":"2021111804085786700_cei12675-bib-0042","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest"},{"key":"2021111804085786700_cei12675-bib-0043","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","author":"Delville","year":"2014","journal-title":"Sci Transl Med"},{"key":"2021111804085786700_cei12675-bib-0044","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1600-6143.2005.00968.x","article-title":"New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis","volume":"5","author":"Vincenti","year":"2005","journal-title":"Am J Transplant"},{"key":"2021111804085786700_cei12675-bib-0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.22.012703.104533","article-title":"CD40\/CD154 interactions at the interface of tolerance and immunity","volume":"22","author":"Quezada","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"2021111804085786700_cei12675-bib-0046","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.imbio.2011.03.010","article-title":"CD40 ligand: a neo-inflammatory molecule in vascular diseases","volume":"217","author":"Hassan","year":"2012","journal-title":"Immunobiology"},{"key":"2021111804085786700_cei12675-bib-0047","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.imlet.2013.07.005","article-title":"The CD40\/CD40L system: a new therapeutic target for disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Immunol Lett"},{"key":"2021111804085786700_cei12675-bib-0048","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N Engl J Med"},{"key":"2021111804085786700_cei12675-bib-0049","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2007080836","article-title":"Urinary CD80 excretion increases in idiopathic minimal-change disease","volume":"20","author":"Garin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0050","first-page":"1263","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"370","author":"Alachkar","year":"2014","journal-title":"N Engl J Med"},{"key":"2021111804085786700_cei12675-bib-0051","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10875-014-0059-7","article-title":"Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation","volume":"34","author":"Baris","year":"2014","journal-title":"J Clin Immunol"},{"key":"2021111804085786700_cei12675-bib-0052","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1681\/ASN.2007111244","article-title":"Induction of T regulatory cells attenuates idiopathic nephrotic syndrome","volume":"20","author":"Le Berre","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0053","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1681\/ASN.2011090914","article-title":"CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis","volume":"23","author":"Wang","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0054","doi-asserted-by":"crossref","first-page":"e111285","DOI":"10.1371\/journal.pone.0111285","article-title":"LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity","volume":"9","author":"Bertelli","year":"2014","journal-title":"PLOS ONE"},{"key":"2021111804085786700_cei12675-bib-0055","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"2021111804085786700_cei12675-bib-0056","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1681\/ASN.2012080784","article-title":"IL-2\/anti-IL-2 complex attenuates renal ischemia\u2013reperfusion injury through expansion of regulatory T cells","volume":"24","author":"Kim","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0057","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1681\/ASN.2011111130","article-title":"IL-2\/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD","volume":"23","author":"Polhill","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0058","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature05543","article-title":"Foxp3-dependent programme of regulatory T-cell differentiation","volume":"445","author":"Gavin","year":"2007","journal-title":"Nature"},{"key":"2021111804085786700_cei12675-bib-0059","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1126\/science.1191996","article-title":"Stability of the regulatory T cell lineage in vivo","volume":"329","author":"Rubtsov","year":"2010","journal-title":"Science"},{"key":"2021111804085786700_cei12675-bib-0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev"},{"key":"2021111804085786700_cei12675-bib-0061","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.06620714","article-title":"T cells: soldiers and spies-the surveillance and control of effector T cells by regulatory T cells","author":"Hall","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021111804085786700_cei12675-bib-0062","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"2021111804085786700_cei12675-bib-0063","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"2021111804085786700_cei12675-bib-0064","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2021111804085786700_cei12675-bib-0065","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/ajt.12834","article-title":"Understanding the CD28\/CTLA-4 (CD152) pathway and its implications for costimulatory blockade","volume":"14","author":"Gardner","year":"2014","journal-title":"Am J Transplant"},{"key":"2021111804085786700_cei12675-bib-0066","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2021111804085786700_cei12675-bib-0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-006-9048-5","article-title":"Purinergic signalling in the immune system. A brief update","volume":"3","author":"Di Virgilio","year":"2007","journal-title":"Purinergic Signal"},{"key":"2021111804085786700_cei12675-bib-0068","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-6147(00)01574-1","article-title":"P2 receptors meet the immune system","volume":"22","author":"Di Virgilio","year":"2001","journal-title":"Trends Pharmacol Sci"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12675","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/183\/2\/166\/41126183\/cei12675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/183\/2\/166\/41126183\/cei12675.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T02:52:32Z","timestamp":1652755952000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/183\/2\/166\/6412192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,10,12]]},"published-print":{"date-parts":[[2016,1,13]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12675","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,2]]},"published":{"date-parts":[[2015,10,12]]}}}